373 Cyp2d6 PPTs View free & download

Double Allelism at CYP2D6 and GSTM1 associated with an Increased Risk of Parkinson's Disease PowerPoint PPT Presentation

Double Allelism at CYP2D6 and GSTM1 associated with an Increased Risk of Parkinson's Disease - Title: Double Allelism at CYP2D6 and GSTM1 associated with an Increased Risk of Parkinson's Disease Author: Piu Chan Last modified by: Xu Yan Created Date

Title: Double Allelism at CYP2D6 and GSTM1 associated with an Increased Risk of Parkinson's Disease Author: Piu Chan Last modified by: Xu Yan Created Date

| PowerPoint PPT presentation | free to view

Drug-Drug Interactions 101 or Will It Take a 2 by 6 to Get You to Understand CYP2D6? PowerPoint PPT Presentation

Drug-Drug Interactions 101 or Will It Take a 2 by 6 to Get You to Understand CYP2D6? - If a patient is currently on oral contraceptives, what mood stabilizer can be ... Patient is on cyclobenzaprine and is depressed. What drug will increase its levels? ...

If a patient is currently on oral contraceptives, what mood stabilizer can be ... Patient is on cyclobenzaprine and is depressed. What drug will increase its levels? ...

| PowerPoint PPT presentation | free to view

Supplemental Data Figure 1A' a Signals produced by the Nanochip duplicationdeletion assay b CYP2D6 c - Supplemental Data Figure 1A' a Signals produced by the Nanochip duplicationdeletion assay b CYP2D6 c

Supplemental Data Figure 1A' a Signals produced by the Nanochip duplicationdeletion assay b CYP2D6 c

| PowerPoint PPT presentation | free to download

Tamoxifen Pharmacogenetics and Prediction of Breast Cancer Relapse After Administration of Tamoxifen PowerPoint PPT Presentation

Tamoxifen Pharmacogenetics and Prediction of Breast Cancer Relapse After Administration of Tamoxifen - Mayo Clinic Cancer Center. North Central Cancer Treatment Group ... Mayo Clinic Breast Cancer SPORE. CYP2D6 Individualized Adjuvant Hormonal Study ...

Mayo Clinic Cancer Center. North Central Cancer Treatment Group ... Mayo Clinic Breast Cancer SPORE. CYP2D6 Individualized Adjuvant Hormonal Study ...

| PowerPoint PPT presentation | free to view

Outlier - Coefficient of variation of exon read depth Gene Exon C.V. CYP2D6 4 0.2043 Outlier exons CYP2D6 5 0.2099 CYP2D6 6 0.1961 CYP2D6 8 0.1903 MLL 5 0.2032 MLL 6 0.2224 MLL

Coefficient of variation of exon read depth Gene Exon C.V. CYP2D6 4 0.2043 Outlier exons CYP2D6 5 0.2099 CYP2D6 6 0.1961 CYP2D6 8 0.1903 MLL 5 0.2032 MLL 6 0.2224 MLL

| PowerPoint PPT presentation | free to download

Pharmacogenetics PowerPoint PPT Presentation

Pharmacogenetics - CLINICAL ASPECTS OF G6PD DEFICIENCY red blood cell can no longer transport ... CYP2D6 a highly polymorphic gene that is inactive in about 6% of Caucasians ...

CLINICAL ASPECTS OF G6PD DEFICIENCY red blood cell can no longer transport ... CYP2D6 a highly polymorphic gene that is inactive in about 6% of Caucasians ...

| PowerPoint PPT presentation | free to view

FDA Clinical Pharmacology Advisory Committee PowerPoint PPT Presentation

FDA Clinical Pharmacology Advisory Committee - Indiana University School of Medicine. Implications of a. CYP2D6 test for tamoxifen ... Germline DNA as a test in breast cancer. ...

Indiana University School of Medicine. Implications of a. CYP2D6 test for tamoxifen ... Germline DNA as a test in breast cancer. ...

| PowerPoint PPT presentation | free to view

Drug Development Clinical Strategies and Planning PowerPoint PPT Presentation

Drug Development Clinical Strategies and Planning - Reverse-Engineering of Phase 3 and Phase 2 Studies. Neil V. Smith, ... Quinidine, desipramine, or metoprolol (CYP2D6 metabolism) Theophylline (CYP1A2 metabolism) ...

Reverse-Engineering of Phase 3 and Phase 2 Studies. Neil V. Smith, ... Quinidine, desipramine, or metoprolol (CYP2D6 metabolism) Theophylline (CYP1A2 metabolism) ...

| PowerPoint PPT presentation | free to view

Oral Clefts, Environmental Exposures, and Genetic Variation of Candidate Genes PowerPoint PPT Presentation

Oral Clefts, Environmental Exposures, and Genetic Variation of Candidate Genes - Oral Clefts, Environmental Exposures, and. Genetic Variation of Candidate Genes ... Xenobiotic metabolizing enzymes. phase 1 : CYP2D6, NAT1, NAT2, EPHX1 ...

Oral Clefts, Environmental Exposures, and. Genetic Variation of Candidate Genes ... Xenobiotic metabolizing enzymes. phase 1 : CYP2D6, NAT1, NAT2, EPHX1 ...

| PowerPoint PPT presentation | free to view

Drug Interactions in Older Adults PowerPoint PPT Presentation

Drug Interactions in Older Adults - Discuss the epidemiology of the different types of drug interactions in the elderly ... CYP2D6 2-4 Codeine, Desipramine, Tramadol. CYP2E1 9-10 Chlorzoxazone, Ethanol ...

Discuss the epidemiology of the different types of drug interactions in the elderly ... CYP2D6 2-4 Codeine, Desipramine, Tramadol. CYP2E1 9-10 Chlorzoxazone, Ethanol ...

| PowerPoint PPT presentation | free to view

Efficiency and power in genetic association studies PowerPoint PPT Presentation

Efficiency and power in genetic association studies - Utilize family data by applying phenotype scores for founder haplotypes ... LDU locations for the 27 SNPs flanking the CYP2D6 gene on chromosome 22, the ...

Utilize family data by applying phenotype scores for founder haplotypes ... LDU locations for the 27 SNPs flanking the CYP2D6 gene on chromosome 22, the ...

| PowerPoint PPT presentation | free to view

in vitro assessment of tipranavir to inhibit cytochrome P450 pathways in the absence of ritonavir PowerPoint PPT Presentation

in vitro assessment of tipranavir to inhibit cytochrome P450 pathways in the absence of ritonavir - 1. in vitro assessment of tipranavir to inhibit cytochrome P450 ... Alprazolam. N. N. N. N. N. N. PGP. CYP3A4. CYP2D6. CYP2C9. CYP2C19. CYP1A2. Substrate. 3 ...

1. in vitro assessment of tipranavir to inhibit cytochrome P450 ... Alprazolam. N. N. N. N. N. N. PGP. CYP3A4. CYP2D6. CYP2C9. CYP2C19. CYP1A2. Substrate. 3 ...

| PowerPoint PPT presentation | free to view

Pharmacogenetics and Pharmacogenomics PowerPoint PPT Presentation

Pharmacogenetics and Pharmacogenomics - Pharmacogenetics and Pharmacogenomics Kevin Zbuk, MD Medical Oncologist Juravinski Cancer Centre McMaster University Effect of Clopidogrel as Compared with Placebo on ...

Pharmacogenetics and Pharmacogenomics Kevin Zbuk, MD Medical Oncologist Juravinski Cancer Centre McMaster University Effect of Clopidogrel as Compared with Placebo on ...

| PowerPoint PPT presentation | free to download

Induction - 45 year-old woman presented with intense, intolerable hot flashes after being ... History of troublesome hot flashes for which treatment with a non-hormonal agent ...

45 year-old woman presented with intense, intolerable hot flashes after being ... History of troublesome hot flashes for which treatment with a non-hormonal agent ...

| PowerPoint PPT presentation | free to view

Drug Metabolism and Pharmacogenetics PowerPoint PPT Presentation

Drug Metabolism and Pharmacogenetics - Drug Metabolism and Pharmacogenetics Brendan Stamper University of Washington Dept. of Medicinal Chemistry * * * * * Figure 2. Two types of variability in drug action.

Drug Metabolism and Pharmacogenetics Brendan Stamper University of Washington Dept. of Medicinal Chemistry * * * * * Figure 2. Two types of variability in drug action.

| PowerPoint PPT presentation | free to view

Pharmacogenetics: Integration into new drug development Academic Perspective PowerPoint PPT Presentation

Pharmacogenetics: Integration into new drug development Academic Perspective - Hyperactive in up to 30% of East Africans. Catalyzes primary metabolism of: codeine ... 2 allele patients had greater clearance than 1 or 0 allele patients. ...

Hyperactive in up to 30% of East Africans. Catalyzes primary metabolism of: codeine ... 2 allele patients had greater clearance than 1 or 0 allele patients. ...

| PowerPoint PPT presentation | free to view

L - Title: PowerPoint-presentation Author: maha Last modified by: Carl-Olav Stiller Created Date: 12/27/2004 1:29:37 PM Document presentation format: Bildspel p ...

Title: PowerPoint-presentation Author: maha Last modified by: Carl-Olav Stiller Created Date: 12/27/2004 1:29:37 PM Document presentation format: Bildspel p ...

| PowerPoint PPT presentation | free to view

PreIMPAKT Training Course DNA PowerPoint PPT Presentation

PreIMPAKT Training Course DNA - Division of Pharmacology Department of Internal Medicine ... in patients homozygous for the 3RG allele compared with others (P = 0.037) ...

Division of Pharmacology Department of Internal Medicine ... in patients homozygous for the 3RG allele compared with others (P = 0.037) ...

| PowerPoint PPT presentation | free to view

Trends Biotech 19: 288,2001 PowerPoint PPT Presentation

Trends Biotech 19: 288,2001 - ... to decipher molecular ... IN GENE EXPRESSION in Mycobacterium tuberculosis (Wilson ... Comprehensive detection of gene variations ...

... to decipher molecular ... IN GENE EXPRESSION in Mycobacterium tuberculosis (Wilson ... Comprehensive detection of gene variations ...

| PowerPoint PPT presentation | free to view

Herb - Drug Interactions PowerPoint PPT Presentation

Herb - Drug Interactions - Safety of Herb - Drug combination treatments

Safety of Herb - Drug combination treatments

| PowerPoint PPT presentation | free to view

Diapositiva 1 PowerPoint PPT Presentation

Diapositiva 1 - The introduction in clinical practice of pharmacogenetics may be useful to improve the ... Pharmacogenomic protocols in CNS disorders and dementia (Cacabelos ...

The introduction in clinical practice of pharmacogenetics may be useful to improve the ... Pharmacogenomic protocols in CNS disorders and dementia (Cacabelos ...

| PowerPoint PPT presentation | free to download

Farmacogen - Farmacogen mica Gen tica aplicada a la optimizaci n de la terapia farmacol gica. F rmaco Sustancia que presenta eficacia en el tratamiento de una enfermedad.

Farmacogen mica Gen tica aplicada a la optimizaci n de la terapia farmacol gica. F rmaco Sustancia que presenta eficacia en el tratamiento de una enfermedad.

| PowerPoint PPT presentation | free to download

Flow of information in a drug discovery pipeline PowerPoint PPT Presentation

Flow of information in a drug discovery pipeline - Title: Cytochrome P450 and Polymorphism Subject: Cytochrome P450, ADME, Polymorphisms Author: Michael Hutter Last modified by: Michael Hutter Created Date

Title: Cytochrome P450 and Polymorphism Subject: Cytochrome P450, ADME, Polymorphisms Author: Michael Hutter Last modified by: Michael Hutter Created Date

| PowerPoint PPT presentation | free to view

Clinical implications of pharmacogenetic research PowerPoint PPT Presentation

Clinical implications of pharmacogenetic research - Frequency of subjects having duplicated ... Ksenia Goryachkina, Aleksandra Bubello, Svetlana Boldueva, Svetlana Babak, Ulf Bergman, Leif Bertilsson ...

Frequency of subjects having duplicated ... Ksenia Goryachkina, Aleksandra Bubello, Svetlana Boldueva, Svetlana Babak, Ulf Bergman, Leif Bertilsson ...

| PowerPoint PPT presentation | free to download

Tipranavir NDA 21-814 Drug Interactions PowerPoint PPT Presentation

Tipranavir NDA 21-814 Drug Interactions - Question for the Antiviral Drugs Advisory Committee. 3 ... TPV/r may increase or decrease warfarin concentrations (competing effects on CYP2C9) ...

Question for the Antiviral Drugs Advisory Committee. 3 ... TPV/r may increase or decrease warfarin concentrations (competing effects on CYP2C9) ...

| PowerPoint PPT presentation | free to view

Cytochrome P450 enzymes - Drug Interactions PowerPoint PPT Presentation

Cytochrome P450 enzymes - Drug Interactions - Cytochrome P450 enzyme inducers and inhibitors are dealt in this presentation.

Cytochrome P450 enzyme inducers and inhibitors are dealt in this presentation.

| PowerPoint PPT presentation | free to view

Clinical Pharmacogenetics PowerPoint PPT Presentation

Clinical Pharmacogenetics - Clinical Pharmacogenetics David A Flockhart MD, PhD Chief, Division of Clinical Pharmacology Professor of Medicine, Genetics and Pharmacology Indiana University ...

Clinical Pharmacogenetics David A Flockhart MD, PhD Chief, Division of Clinical Pharmacology Professor of Medicine, Genetics and Pharmacology Indiana University ...

| PowerPoint PPT presentation | free to view

Farmacogen - Metabolizadores lentos: 10-20 mg/d a. Metabolizadores ultrarr pidos: ... Los acetiladores lentos tienen una frecuencia del 50% en poblaciones europeas. 12/28/09 ...

Metabolizadores lentos: 10-20 mg/d a. Metabolizadores ultrarr pidos: ... Los acetiladores lentos tienen una frecuencia del 50% en poblaciones europeas. 12/28/09 ...

| PowerPoint PPT presentation | free to download

Monitoring Drug Efficacy PowerPoint PPT Presentation

Monitoring Drug Efficacy - Monitoring Drug Efficacy & Toxicity - along with drug metabolism Michael E. Hodsdon, MD, PhD Associate Professor Departments of Laboratory Medicine & Pharmacology

Monitoring Drug Efficacy & Toxicity - along with drug metabolism Michael E. Hodsdon, MD, PhD Associate Professor Departments of Laboratory Medicine & Pharmacology

| PowerPoint PPT presentation | free to download

Diapositiva 1 - XENOBIOTICI Composti estranei all organismo Contaminanti ambientali assorbiti attraverso la pelle, i polmoni o introdotti con l alimentazione

XENOBIOTICI Composti estranei all organismo Contaminanti ambientali assorbiti attraverso la pelle, i polmoni o introdotti con l alimentazione

| PowerPoint PPT presentation | free to download

Pharmacogenetics: What is it How do I measure it What does it mean to me PowerPoint PPT Presentation

Pharmacogenetics: What is it How do I measure it What does it mean to me - Metoprolol Exposure with Equal Weight Doses-Reduced Metabolism in Asians. 10 EMs (Caucs) and 6 PMs (Asians) took metoprolol daily for 5 days ...

Metoprolol Exposure with Equal Weight Doses-Reduced Metabolism in Asians. 10 EMs (Caucs) and 6 PMs (Asians) took metoprolol daily for 5 days ...

| PowerPoint PPT presentation | free to view

General Session 4: Pharmacogenomics PowerPoint PPT Presentation

General Session 4: Pharmacogenomics - Multiplex Tests for Heritable DNA Markers, Mutations and Expression Patterns: ... Roche AmpliChip CYP450 Test (CDRH de novo 510(k) K042259) ...

Multiplex Tests for Heritable DNA Markers, Mutations and Expression Patterns: ... Roche AmpliChip CYP450 Test (CDRH de novo 510(k) K042259) ...

| PowerPoint PPT presentation | free to view

Pharmacogenetics and the Management of Breast Cancer: Optimization of Tamoxifen Therapy PowerPoint PPT Presentation

Pharmacogenetics and the Management of Breast Cancer: Optimization of Tamoxifen Therapy - Pharmacogenetics and the Management of Breast Cancer: Optimization of Tamoxifen Therapy Mark E. Sobel, M.D., Ph.D. Executive Officer American Society for ...

Pharmacogenetics and the Management of Breast Cancer: Optimization of Tamoxifen Therapy Mark E. Sobel, M.D., Ph.D. Executive Officer American Society for ...

| PowerPoint PPT presentation | free to view

Pharmacogenetics - Pharmacogenetics Plays a Role ... 5-Fluorouracil Catabolism ... DPD is responsible for catabolism of 5-fluorouracil. This accounts for 85% of drug metabolism ...

Pharmacogenetics Plays a Role ... 5-Fluorouracil Catabolism ... DPD is responsible for catabolism of 5-fluorouracil. This accounts for 85% of drug metabolism ...

| PowerPoint PPT presentation | free to view

Chapter 8 Quality of Life Assessment - Chapter 8 Quality of Life Assessment

Chapter 8 Quality of Life Assessment

| PowerPoint PPT presentation | free to view

Personalized Medicine: Its Coming Impact on the Health Care System PowerPoint PPT Presentation

Personalized Medicine: Its Coming Impact on the Health Care System - Use of genetic information for treatment decisions & drug development ... E.g., Prozac, Tamixofen, Claritan, Inderal, Codeine, Vicodin ...

Use of genetic information for treatment decisions & drug development ... E.g., Prozac, Tamixofen, Claritan, Inderal, Codeine, Vicodin ...

| PowerPoint PPT presentation | free to view

RExPrimer - Pongsakorn Wangkumhang, M.Sc. Biostatistics and Informatics Laboratory, Genome Institute, ... Graphical user interface for visualizing gene structure is crucial ...

Pongsakorn Wangkumhang, M.Sc. Biostatistics and Informatics Laboratory, Genome Institute, ... Graphical user interface for visualizing gene structure is crucial ...

| PowerPoint PPT presentation | free to download

Genetic polymorphism PowerPoint PPT Presentation

Genetic polymorphism - Genetic polymorphism & drug interactions in pain management Prof Ian Whyte, FRACP, FRCPE Calvary Mater Newcastle University of Newcastle P-glycoprotein Transmembrane ...

Genetic polymorphism & drug interactions in pain management Prof Ian Whyte, FRACP, FRCPE Calvary Mater Newcastle University of Newcastle P-glycoprotein Transmembrane ...

| PowerPoint PPT presentation | free to view

DOLOR Y OPIOIDES PowerPoint PPT Presentation

DOLOR Y OPIOIDES - julio cesar garcia casallas medicina interna farmacologia clinica morfina ugt2b7 ugt1a8 ugt2a1 normorfina morfina-3-glucur nido morfina-6-glucuronido morfina ...

julio cesar garcia casallas medicina interna farmacologia clinica morfina ugt2b7 ugt1a8 ugt2a1 normorfina morfina-3-glucur nido morfina-6-glucuronido morfina ...

| PowerPoint PPT presentation | free to download

Gene Related Metabolism of Drugs PowerPoint PPT Presentation

... excellent example of both the potential clinical implications and the process by which gene research led from the phenotype to an understanding of molecular ...

| PowerPoint PPT presentation | free to view

DRUG TREATMENT IN THE ELDERLY PowerPoint PPT Presentation

DRUG TREATMENT IN THE ELDERLY - Drug treatment increases (almost exponentially) with age ... adrenergic drugs. Unchanged responsiveness. most drugs. Increased responsiveness. benzodiazepines ...

Drug treatment increases (almost exponentially) with age ... adrenergic drugs. Unchanged responsiveness. most drugs. Increased responsiveness. benzodiazepines ...

| PowerPoint PPT presentation | free to download

Depression im Alter PowerPoint PPT Presentation

Depression im Alter - Dr. R. Stettler Sonnenhalde Klinik f r Psychiatrie und Psychotherapie 4125 Riehen / Basel Depression im Alter: Involutionsdepression? seltener positive FA ...

Dr. R. Stettler Sonnenhalde Klinik f r Psychiatrie und Psychotherapie 4125 Riehen / Basel Depression im Alter: Involutionsdepression? seltener positive FA ...

| PowerPoint PPT presentation | free to view

Dextromethorphan DXM PowerPoint PPT Presentation

Dextromethorphan DXM - ... which are in sync with the hippocampus that passes through the cingulate cortex. Activate neurons in the posterior cingulate cortex (PC) and retrosplenial cortex ...

... which are in sync with the hippocampus that passes through the cingulate cortex. Activate neurons in the posterior cingulate cortex (PC) and retrosplenial cortex ...

| PowerPoint PPT presentation | free to view

HIV JO Slide Template PowerPoint PPT Presentation

HIV JO Slide Template - Title: HIV JO Slide Template Author: Preferred User Created Date: 5/27/2005 3:08:01 PM Document presentation format: Presentazione su schermo Company

Title: HIV JO Slide Template Author: Preferred User Created Date: 5/27/2005 3:08:01 PM Document presentation format: Presentazione su schermo Company

| PowerPoint PPT presentation | free to view

Pharmacogenomics: The Promise of Personalized Medicine PowerPoint PPT Presentation

Pharmacogenomics: The Promise of Personalized Medicine - Human Genome Project. Determine the sequence of the 3 billion nucleotides that make up human DNA ... Composition of the Human Genome. Mutation/Polymorphism 1 bp ...

Human Genome Project. Determine the sequence of the 3 billion nucleotides that make up human DNA ... Composition of the Human Genome. Mutation/Polymorphism 1 bp ...

| PowerPoint PPT presentation | free to view

Genetic polymorphism: (i) individual handling of drugs (ii) inherited susceptibility to disease PowerPoint PPT Presentation

Genetic polymorphism: (i) individual handling of drugs (ii) inherited susceptibility to disease - Genetic polymorphism: (i) individual handling of drugs (ii) inherited susceptibility to disease Much individuality in drug response is inherited (polymorphism ...

Genetic polymorphism: (i) individual handling of drugs (ii) inherited susceptibility to disease Much individuality in drug response is inherited (polymorphism ...

| PowerPoint PPT presentation | free to view

Medical Update for Women Living with Advanced Breast Cancer PowerPoint PPT Presentation

Medical Update for Women Living with Advanced Breast Cancer - Medical Update for Women Living with Advanced Breast Cancer. Julie R. Gralow, M.D. ... Approved for treatment of advanced breast cancer ...

Medical Update for Women Living with Advanced Breast Cancer. Julie R. Gralow, M.D. ... Approved for treatment of advanced breast cancer ...

| PowerPoint PPT presentation | free to view

Psicof - Psicof rmacos y Arritmias Card acas Dr. Walter Reyes Caorsi, FACC Montevideo-Uruguay

Psicof rmacos y Arritmias Card acas Dr. Walter Reyes Caorsi, FACC Montevideo-Uruguay

| PowerPoint PPT presentation | free to view

1000 Drug Interactions That You Didn PowerPoint PPT Presentation

1000 Drug Interactions That You Didn - war tet ter pro phe nif iro flu ery dig cim (Don't forget to turn the corner! ... war tet ter pro phe nif iro flu ery dig cim. A. A. A. Phase 1 (usually ...

war tet ter pro phe nif iro flu ery dig cim (Don't forget to turn the corner! ... war tet ter pro phe nif iro flu ery dig cim. A. A. A. Phase 1 (usually ...

| PowerPoint PPT presentation | free to download

Dextromethorphan Abuse in Adolescence: A Rising Trend PowerPoint PPT Presentation

Dextromethorphan Abuse in Adolescence: A Rising Trend - Dextromethorphan Abuse in Adolescence: A Rising Trend Ilene B. Anderson, PharmD Clinical Professor; UCSF School of Pharmacy Senior Toxicologist California Poison ...

Dextromethorphan Abuse in Adolescence: A Rising Trend Ilene B. Anderson, PharmD Clinical Professor; UCSF School of Pharmacy Senior Toxicologist California Poison ...

| PowerPoint PPT presentation | free to view

Pharmacogenomics and Pharmacogenetics: Are We Ready for Personalized Medicine? David Gurwitz Sackler Faculty of Medicine, Tel-Aviv University GRIB, Barcelona, July 12, 2005 - Abraham Weizman. Neta Roz. Tal Barkan. Galit Levi. Y-chromosome: ... Yvonne Wan et al (University of Kansas) Kenji Nakai et al (Iwate Medical University) ...

Abraham Weizman. Neta Roz. Tal Barkan. Galit Levi. Y-chromosome: ... Yvonne Wan et al (University of Kansas) Kenji Nakai et al (Iwate Medical University) ...

| PowerPoint PPT presentation | free to view

Breast Cancer - Breast Cancer

Breast Cancer

| PowerPoint PPT presentation | free to view

Cytochrom P450, Polymorphismus, Transporter PowerPoint PPT Presentation

Cytochrom P450, Polymorphismus, Transporter - Title: Modern Methods in Drug Discovery Subject: Cytochrom P450, Polymorphismus, Transporter Author: Michael Hutter Last modified by: Michael Hutter

Title: Modern Methods in Drug Discovery Subject: Cytochrom P450, Polymorphismus, Transporter Author: Michael Hutter Last modified by: Michael Hutter

| PowerPoint PPT presentation | free to view

Drug Interactions Clinical Pharmacology Spring Course 2006 PowerPoint PPT Presentation

Drug Interactions Clinical Pharmacology Spring Course 2006 - Pharmacokinetic: Elimination ... benzodiazeines- diazepam, midazolam; cyclosporine, tacrolimus,; HIV Protease Inhibitors indinavir, ritonavir; chlorpheniramine; ...

Pharmacokinetic: Elimination ... benzodiazeines- diazepam, midazolam; cyclosporine, tacrolimus,; HIV Protease Inhibitors indinavir, ritonavir; chlorpheniramine; ...

| PowerPoint PPT presentation | free to download

ADME - ADME METABOLISM ADME METABOLISM Strictly the biological breakdown (catabolism) or synthesis (anabolism) of compounds. ADME METABOLISM Strictly the biological ...

ADME METABOLISM ADME METABOLISM Strictly the biological breakdown (catabolism) or synthesis (anabolism) of compounds. ADME METABOLISM Strictly the biological ...

| PowerPoint PPT presentation | free to view

Treatment During Pregnancy: Gaps in our Knowledge PowerPoint PPT Presentation

Treatment During Pregnancy: Gaps in our Knowledge - 75% of drugs used in pediatrics not tested in kids ... Evaluated the 10 drugs withdrawn from US market from Jan '97 Dec 2000 ...

75% of drugs used in pediatrics not tested in kids ... Evaluated the 10 drugs withdrawn from US market from Jan '97 Dec 2000 ...

| PowerPoint PPT presentation | free to download

Cyp2d6 PowerPoint PPT Presentations